Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Fedorak

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Annals of Internal Medicine|September 1, 1986
Failing to detect occult bloodD M Hovsepian, M E Linskey, R Fedorak
Canadian Family Physician Medecin De Famille Canadien|April 1, 1993
Therapeutic role of dietary fibreR Hunt, R Fedorak, J Frohlich, et al.
Biochimica Et Biophysica Acta|April 20, 1994
Crypt cell production rate, enterocyte turnover time and appearance of transport along the jejunal villus of the ratA B Thomson, C I Cheeseman, M Keelan, et al.
Digestive Diseases (Basel, Switzerland)|January 1, 1990
Radiation and the small intestine. Future perspectives for preventive therapyS Churnratanakul, B Wirzba, T Lam, et al.
Digestive Diseases (Basel, Switzerland)|January 1, 1990
Patterns, mechanisms and signals for intestinal adaptationA B Thomson, M Keelan, D Sigalet, et al.
Gut|August 13, 2003
Interferon beta-1a in ulcerative colitis: a placebo controlled, randomised, dose escalating studyS Nikolaus, P Rutgeerts, R Fedorak, et al.
JPEN. Journal of Parenteral and Enteral Nutrition|November 2, 2001
Nutritional effects of surgical and medical treatment for short bowel syndromeD L Sigalet, G M Lees, F X Aherne, et al.
Alimentary Pharmacology & Therapeutics|November 14, 1997
Short-course therapy with amoxycillin-clarithromycin triple therapy for 10 days (ACT-10) eradicates Helicobacter pylori and heals duodenal ulcer. ACT-10 Study GroupH Wurzer, L Rodrigo, D Stamler, et al.
Alimentary Pharmacology & Therapeutics|December 5, 2008
Clinical trial: intravenous pantoprazole vs. ranitidine for the prevention of peptic ulcer rebleeding: a multicentre, multinational, randomized trialC van Rensburg, A N Barkun, I Racz, et al.
International Journal of Colorectal Disease|April 25, 2001
Use of anti-tumour necrosis factor agents in inflammatory bowel disease. European guidelines for 2001-2003S Schreiber, M Campieri, J F Colombel, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Annals of Internal Medicine|September 1, 1986
Failing to detect occult bloodD M Hovsepian, M E Linskey, R Fedorak
Canadian Family Physician Medecin De Famille Canadien|April 1, 1993
Therapeutic role of dietary fibreR Hunt, R Fedorak, J Frohlich, et al.
Biochimica Et Biophysica Acta|April 20, 1994
Crypt cell production rate, enterocyte turnover time and appearance of transport along the jejunal villus of the ratA B Thomson, C I Cheeseman, M Keelan, et al.
Digestive Diseases (Basel, Switzerland)|January 1, 1990
Radiation and the small intestine. Future perspectives for preventive therapyS Churnratanakul, B Wirzba, T Lam, et al.
Digestive Diseases (Basel, Switzerland)|January 1, 1990
Patterns, mechanisms and signals for intestinal adaptationA B Thomson, M Keelan, D Sigalet, et al.
Gut|August 13, 2003
Interferon beta-1a in ulcerative colitis: a placebo controlled, randomised, dose escalating studyS Nikolaus, P Rutgeerts, R Fedorak, et al.
JPEN. Journal of Parenteral and Enteral Nutrition|November 2, 2001
Nutritional effects of surgical and medical treatment for short bowel syndromeD L Sigalet, G M Lees, F X Aherne, et al.
Alimentary Pharmacology & Therapeutics|November 14, 1997
Short-course therapy with amoxycillin-clarithromycin triple therapy for 10 days (ACT-10) eradicates Helicobacter pylori and heals duodenal ulcer. ACT-10 Study GroupH Wurzer, L Rodrigo, D Stamler, et al.
Alimentary Pharmacology & Therapeutics|December 5, 2008
Clinical trial: intravenous pantoprazole vs. ranitidine for the prevention of peptic ulcer rebleeding: a multicentre, multinational, randomized trialC van Rensburg, A N Barkun, I Racz, et al.
International Journal of Colorectal Disease|April 25, 2001
Use of anti-tumour necrosis factor agents in inflammatory bowel disease. European guidelines for 2001-2003S Schreiber, M Campieri, J F Colombel, et al.
Pageof 1